The Bharat Biotech hopes to have a vaccine license for children by the third quarter of the year. By the end of this year, the company will produce 700 million covaxin doses. Government has already given an order of Rs 1500 crore in advance.
In the wake of anticipation of a third wave of corona in the country, the company making Covaxin is going to start a trial of anti-covid vaccine for children from next month. Bharat Biotech’s Head of Business Development and International Advocacy, Dr. Raches Ella, said the company could begin paediatric trials of its anti-covid vaccine Covaxin from June. Recently, Bharat Biotech received validation from the Drug Controller General of India for clinical trials for children aged 2-18 years.
In a virtual conversation with members of the FICCI Ladies Organization in Hyderabad, said this on behalf of the company. The company's business heads, Dr. Raches Ella, said that the company expects to get the Covaxin authorized by the World Health Organization by the third or fourth quarter of this year. In response to a question, Dr. Ella said that we are happy that our hard work is paying off. Right now, Covaxin is doing a good job on coronavirus infection and saving people's lives.
Dr. Ella said that the government has got full cooperation in the journey so far. He said that this vaccine has been made in association with ICMR. The government has ordered a vaccine worth Rs 1,500 crore in advance. At the same time, the company is also expanding in Bangalore and Gujarat. The company will increase its vaccine production capacity to 70 million doses by the end of this year.
Hoping WHO to approve Covaxin, the company official said, "We have begun the approval process from the World Health Organization. We hope to get it soon. He exuded confidence that by the third quarter of this year the company would get a license for the vaccine for children. He said that now our focus is to increase vaccine production capacity.
Many health experts have predicted that children are most affected in the third wave of corona. In such a situation, it is important to have an effective and safe vaccine available for children before the third wave. Three vaccines Covishield, Covaxin and Russia's Sputnik V have received emergency use validation against Corona infection so far in the country.
The Brief. Sign up to receive the top stories you need to know right now.